| 标题 |
Ivarmacitinib, a selective Janus kinase 1 inhibitor, in patients with moderate-to-severe active rheumatoid arthritis and inadequate response to conventional synthetic DMARDs: results from a phase III randomised clinical trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:Annals of the Rheumatic Diseases 作者:Jinjing Liu; Ying Jiang; Shangzhu Zhang; Shengyun Liu; Jingbo Su; et al 出版日期:2025-02-01 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)